Inovio Pharmaceuticals, Inc. (INO)
1.27
-0.02
(-1.55%)
USD |
NASDAQ |
Aug 31, 16:00
1.27
0.00 (0.00%)
After-Hours: 07:22
Inovio Pharmaceuticals Cash from Operations (Annual) : -88.63M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -88.63M |
| December 31, 2024 | -104.08M |
| December 31, 2023 | -124.37M |
| December 31, 2022 | -216.22M |
| December 31, 2021 | -215.71M |
| December 31, 2020 | -177.98M |
| December 31, 2019 | -97.85M |
| December 31, 2018 | -73.55M |
| December 31, 2017 | -63.21M |
| December 31, 2016 | -62.56M |
| December 31, 2015 | -12.44M |
| December 31, 2014 | -29.92M |
| Date | Value |
|---|---|
| December 31, 2013 | -15.38M |
| December 31, 2012 | -22.31M |
| December 31, 2011 | -19.76M |
| December 31, 2010 | -11.94M |
| December 31, 2009 | -14.08M |
| December 31, 2008 | -11.13M |
| December 31, 2007 | -11.51M |
| December 31, 2006 | -7.043M |
| December 31, 2005 | -12.34M |
| December 31, 2004 | -7.057M |
| December 31, 2003 | -5.788M |
| December 31, 2002 | -4.960M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Fortress Biotech, Inc. | -71.34M |
| Tonix Pharmaceuticals Holding Corp. | -99.84M |
| Kura Oncology, Inc. | -64.06M |
| Spero Therapeutics, Inc. | -12.62M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |